Global Mental Health Summit
Program
Agenda for the Private Public Sector Roundtable
Corporate Luncheon (Presidential Hall Main Floor)
Thursday 11th, 2025 Evening Cocktail
Friday, December 12th, 2025
New York Academy of Medicine
103rd St & 5th Avenue, New York City
GLOBAL MENTAL HEALTH SUMMIT THE AMERICAN IBOGAINE INITIATIVE: A BIPARTISAN IBOGAINE RESEARCH BILL 2026 - SIGN THE PETITION
The Knowledge Recovery Foundation/ Institute (KRFI), a Public Benefit Corporation, a 501(c)(3) nonprofit research and clinical development organization, today announced the American Ibogaine Initiative: A Bipartisan Call to NYS Ibogaine Research Bill for Governor Hochul's sign off during the January General Senate Assembly in NYS, Albany. KRFI is conducting a two-day Global Drug Policy for Mental Health and KRFI Gala Award Dinner fundraising event at the New York Academy of Medicine on December 11–12, 2025. The December 12th event will launch the Global Mental Health Security Fund’s matching allocation to $300 million for other opioid FDA Clinical Trial Grant funding by signing off on the NYS Bipartisan Ibogaine Research grant, supporting the nation’s first-ever FDA clinical trial for ibogaine in the treatment of Opioid Use Disorder (OUD) / Substance. Use Disorder, TBI, Parkinson's Diseases.
This historic Ibogaine research bill initiative unites state leadership, federal regulators, scientific researchers, and global public–private partners to advance safe, ethical, and science-based clinical access to ibogaine, a plant-derived compound showing potential to transform addiction treatment and mental health care.
Global Mental Health Summit Program Overview
Title: The American Ibogaine Initiative: A Bipartisan Call to Healing “Ibogaine Research Act”
Dates: December 12th, 2025
Venue: The New York Academy of Medicine 103rd St & 5th Ave, NYC., New York
Hosted by: Knowledge Recovery Foundation Institute (KRFI) in Private Public Sector Partnership with the Global Mental Health Security Fund
The program will feature a Mental Health Policy & Science Roundtable on Thursday, December 12th, 2025
leveening aunched with Corporate cocktail at 7 PM in the 1st Floor Presidential Hall
Speakers invited are Governor Kathy Hochul, Attorney General Letitia James, Bryan Hubbard, Director of Americans for Ibogaine, James Hunt, Former DEA chief, and other UN Missions and Ambassadors for the Ibogaine PPP ABS-IP with UNCED agreements.
A Turning Point in Ibogaine Addiction Research and Global Mental Health Policy
The initiative represents a bipartisan breakthrough in U.S. mental health policy, connecting New York State and Texas through a unified clinical research consortium and establishing an international Access and Benefit-Sharing (ABS) framework for sustainable ibogaine production in Brazil, Gabon, Ghana, Cameroon, DRC, and Costa Rica and others.
The event’s proceeds will fund KRFI’s Contract Research Organization (CRO) and Clinical Trial Management System (CTMS) platform, supporting the FDA Investigational New Drug (IND) application for ibogaine and accelerating cross-border data integration for clinical, regulatory, and environmental traceability.
December 12th, Thursday Hosack Hall (Auditorium 1st Floor)
Opening Remarks and Keynote Speaker
-
8:00 AM Private Public Sector Corporate Breakfast at Presidential Hall, 1st Floor, Global Mental Health Security Partnership investment meeting
-
9:00-10:30 AM Moderated by W. Bryan Hubbard, Mental Health Security Fund and Ibogaine Consortium (TBA) Creating a Private Public Sector Partnership in Ibogaine Clinical Research in NYS, TX, and USA – Global Private Public Sector Partnership on the Ibogaine Access for Benefit Sharing Moderated by Bryant Hubbard, Ibogaine for Americans
-
10:00 AM - 12:00 PM Keynote speaker and Panel Discussion Moderated with policy view with Rick Perry, Former Governor of Texas, NYS Commissioner Sullivan, of Mental Health, Natalie Rodriguez, and Linda Rosenthal, NYS Senate, are the invitees.
Afternoon Event Highlights
Lunch on Main Floor Reception Hall (Presidential Hall 1st Floor) 12:00 3rd Floor
-
1:00–2:30 PM: Moderated by MyungHi S. Lee. Global alliance on FDA/MHRA/EMEA/ANIVSA registered Clinical Trial Reporting and collaboration for ABS-IP, DSCS Hyperledger, as a dashboard for NYS OASAS Ibogaine Research Bill.
-
Global Clinical Research Alliance Atai in the UK, MHRA for Ibogaine, Norwegian CTA, CU Medical School with IboOxy, Gilgamesh, Hakim Djaballah, Ph.D, GCET LLC. / Bruno Rasmussen, M.D., ANIVSA (AUD) Phystan Brazil, National Consortium for Ibogaine KRFI Clinical Research PPP Speakers, Leading Private Public Sector Partnership Ibogaine for Psychedelic and Progress of funding Norwegian EMEA Ibogaine CT, Clear Sky Canadian Ibogaine Clinical Trial, ICEER clinical trial reporting alliance with UCLA Psychedelic Medical Trial network reporting.
-
2:30 - 4:00 PM Global Mental Health Security Fund: Roundtable Investment for Ibogaine and Psychedelics. (TBA) Private Sector Partnership meeting for Access for Benefit Sharing-IP.
-
Moderated by Alex Soros, OSF (TBA), Tropical Nations and Ibogaine ABS-IP for the Private Public Sector Partnership in-country partnership workshop:
-
4:00 -5:30 PM Moderated by Commissioner Joanne Morne for Human Rights (TBA) Drug Supply Chain Security Hyperledger, Roundtable for Implementation NYS OASAS, Former DEA Chief, James Hunt, for the implementation of the “Drug Supply Chain Security Act” and State-level dashboard integration as in state-led bipartisan ibogaine research bill for the FDA Clinical Trial of Ibogaine, Opioid/Substance use disorder. The Drug Supply Chain Security Hyperledger aims to safeguard Opioid Synthetic Drugs for compliance with local tracing and tracking.
-
Health Equity and Human Rights in State-operated PPP for Ibogaine for Veterans and Indigenous Tribal Access.
-
5:30 - 6:30 PM Director of LEAF Coalition (TBA) for Biodiversity and Carbon Credit Technologies for the PPP for Indigenous Entheogens Agricultural Programs and Biodiversity & Carbon Credit protocols for US and Emerging Market Private Public Sector Partnerships. Panel to be announced. Future Impact of Synthetic Ibogaine and ABS IP. Panel to be announced, Moderated by Alice Hoot JD (TBA), Chacuna Indigenous IP Leaders for Central America: Costa Rica and KRIBB Extractive Library and the ABS-IP for Genomics and Chemical Library Data Silos for ABS-IP registrations.
WORKSHOP PROGRAM
Friday, December 12th, 2025 Workshop Breakout 2nd Floor Room 21
9:00 - 10:30 PM Workshop 1 breakout 2nd Floor Room 21: Panel Speakers: Psychedelics VC, Home Office and PPM, Securities and IPs. (TBA) Moderated by Margret Luge, Psychedelics Insight Moderator of 2025-2030, Prospective Mental Health product development investment, Ibogaine & Psychedelics Portfolios. Panel Speakers: Psychedelics VC, Home Office, and PPM, Securities, and IPs. (TBA)
10:30-12:00 AM Workshop 2 Breakout 2nd Floor Room 21
Moderated by W. Bryan Hubbard, Mental Health Security Fund and Ibogaine Consortium (TBA) Creating a Private Public Sector Partnership in Ibogaine Clinical Research in NYS, TX, and USA – Global Private Public Sector Partnership on the Ibogaine Access for Benefit Sharing Moderated by Bryant Hubbard, Ibogaine for Americans
2:30 - 4:00 pm Workshop 3: Breakout 2nd Floor Room 21
Moderated by Commissioner Sullivan, Mental Health (TBA) Investing in Private Public Sector Partnership and Consortium Structure for Bipartisan Ibogaine Research Act & Policy Roundtable with Dr. Chinazo Cunningham of the Commission (TBA), Reporting on the Bipartisan Bill with potential matching fund by Global Mental Health Security Fund for the “Ibogaine Research Act” to match Texas in 300 Mn for the OUD/SUD
4:00 – 5:30 pm: Workshop 4 Breakout 2nd Floor Room 21 Panel Speakers: Psychedelics VC, Home Office and PPM, Securities and IPs. (TBA) Moderated by Andrew Romero, Panel Speakers: Psychedelics VC, Home Office, and PPM, Securities, and IPs. (TBA) Prospective Mental Health product development investment, Ibogaine & Psychedelics Portfolios.
“Addressing addiction requires both courage and innovation. The Ibogaine Initiative unites justice reform and medical science under one shared goal: saving lives.”
MyungHi Sonserai Lee
Sponsorship and Attendance
Table Sponsorships: $25,000 Silver, $50,000 Gold Sponsor; Platinum Sponsor: $100,000
Individual Tickets: $250 individual members, $500 Partnering members, $2,500 Corporate members;
All contributions are tax-deductible and support the KRFI “Ibogaine Research Act” in Consortium successes of the KRFI Questors FDA Clinical Trial Initiative and the Global Mental Health Security Fund.
RSVP by Decemberr 8, 2025
📧 events@krfi.org/Register 🌐 www.krfi.org/donate
“Nations that conscript policies of guns and drugs as personal protection weaponize their own youth. The war against addiction begins with peace in the human mind.”
MyungHi Sonserai Lee
Founder, Knowledge Recovery Foundation/Institute
About the Knowledge Recovery Institute (KRFI)
The Knowledge Recovery Institute (KRFI) is a 501c3 nonprofit scientific organization dedicated to advancing Drug Policy and Drug Research for neglected diseases, including Ibogaine and psychedelic medicine, and in bringing indigenous knowledge of natural products through FDA-regulated clinical research. KRFI’s Questors: AI-driven hyperledger-based clinical trial management, Hyperledger and Tokination of Data Silos for the Biodiversity and Carbon credit-driven protocols, in the private-public partnerships for the Global Mental Health Task Force. KRFI serves as the Contract Research Organization (CRO) for the American Ibogaine Initiative, with Global Ibogaine Therapeutics Alliance through Original Manhattan Project, developing ethical access, supply chain transparency, and clinical validation of ibogaine-based therapies.
About the Global Mental Health Security Fund (GMHSF)
The Global Mental Health Security Fund mobilizes philanthropic and public-sector investment into scalable, data-driven solutions for addiction, trauma, and mental health innovations and technologies. Through matching funds and impact infrastructure, GMHSF supports clinical trials, global regulatory alignment, and biodiversity-driven ABS/IP security and Drug Supply Chain Security Hyperledger.
Media Contact
Press Inquiries:
📩 media@krfi.org | 📞 (212) 722 3960
Press Kit: www.krfi.org/press
Event Media Access Request: www.krfi.org/ibogaineinitiative
Honorary Chairman
George Soros, OSF Chairman/Alex Soros, OSFPresident
Attorney General Leticia James
James Hunt, Former DEA Chief
KRFI NYS Mental Health Security Task Force: Ibogaine Research Act Committee
Brian Kolodny, JP Morgan Chase
Andrew Romero, Managing Director, Global Mental Health Security Fund
Terrance Keeley, ESG Evaluation Lab
Drug Policy and Ibogaine Research Act Tx, Az, OH, NYS
Brian Hubbard, JD, Americans for Ibogaine.org
MyungHI Sonserai Lee DAOM, KRFI Questors for Ibogaine ABS-IP
Alison Hoot JD, Chacuna for Indigenous ABS-IIP
Lisa Gora, JD, NJ Psilocybin Bill Legislature
Program Committee Officers:
Petition Director Marcelo Maia
Media Director: Paul Sladkus, press@krfi.org
Andrew Romero, Investment Relations Outreach
Media Presenter: Aron Ranen
Global Ibogaine for Research Act: A Consortium for Private Public Sector Partnership
American for Ibogaine
Knowledge Recovery Institute
Global Ibogaine Therapist Alliance (GITA) - NYS
Association for Prescriptive Psychedelics
Open Society Foundation
Corporate Sponsor
Psychedelic initiative
Psychedelic Association
American Botanical Association
Sponsored by
NYS HHS, NYS Commission for Human Rights, and OASAS,
UNCBD, WHO, UNEP